Analyst Ratings for Genomic Health Inc. (GHDX)

Updated: 2017-07-28

Genomic Health Inc. (NASDAQ:GHDX) was awarded an average rating of Hold from investment analysts following the stock. A consensus rating of Hold was previously issued for GHDX last month.

3 analysts declared GHDX a buy, 0 issued an overweight rating, 8 issued a hold rating, 1 gave an underweight rating, and 1 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has decreased by 1. During this time, the number of analysts bearish on the stock has increased by 0.

A number of analysts gave price targets for GHDX. The most optimistic price target was 40, implying potential capital gains of 23.65 percent. The most pessimistic price target was 27, implying a possible loss of -16.54 percent. Note that investment analysts can be biased in their reporting on companies's ratings and price targets.

In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 0 percent. The average change in earnings estimates over the last 90 days is -200 percent. On the other hand, earnings estimates for the fiscal year have been revised upwards by 0 percent, as compared to a month ago. If we look at the last 90 days instead, we find a net average change of -25 percent in FY estimates.

Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. 0 analysts have revised their quarterly estimates upwards in the past 30 days, which can be compared to the 0 analysts that decreased their estimates. Also over the last month, 0 analysts increased their estimates for the FY earnings, while 0 analysts made negative revisions to their fiscal year's estimates.

GHDX has traded between a high of 33.97 and a low of 25.66 over the past year. Currently the stock is 26.07 percent higher than its low, and below the high by 4.77 percent. GHDX has a price/earnings ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The GHDX value stock report compares GHDX to some of its peers using value stock charts. The market cap of GHDX is $1.1 billion. GHDX will post this quarters earnings in days, on 0000-00-00.